We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-4.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$89.7B
AUM Growth
-$6.37B
Cap. Flow
-$1.25B
Cap. Flow %
-1.39%
Top 10 Hldgs %
19.07%
Holding
4,574
New
72
Increased
2,420
Reduced
1,279
Closed
355

Sector Composition

Rank Sector Weight
1 Technology 21.66%
2 Healthcare 16.22%
3 Financials 13.45%
4 Consumer Discretionary 9.63%
5 Industrials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WT icon
2501
WisdomTree
WT
$3.22B
$673K ﹤0.01%
143,879
+712
+0.5% +$3.64K
MNDY icon
2502
monday.com
MNDY
$3.94B
$671K ﹤0.01%
5,916
+667
+13% +$79K
GMAB icon
2503
Genmab
GMAB
$19.5B
$669K ﹤0.01%
20,832
-20,540
-50% -$721K
AMPL icon
2504
Amplitude
AMPL
$1.41B
$668K ﹤0.01%
43,141
-13,071
-23% -$210K
BRSP
2505
BrightSpire Capital
BRSP
$648M
$666K ﹤0.01%
105,513
+22,472
+27% +$186K
DNUT icon
2506
Krispy Kreme
DNUT
$577M
$666K ﹤0.01%
57,695
+5,687
+11% +$74.8K
ARQT icon
2507
Arcutis Biotherapeutics
ARQT
$3.18B
$665K ﹤0.01%
34,853
+17,112
+96% +$388K
IPI icon
2508
Intrepid Potash
IPI
$469M
$664K ﹤0.01%
16,787
+4,450
+36% +$193K
IGIB icon
2509
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$660K ﹤0.01%
13,669
+2,180
+19% +$111K
PEBO icon
2510
Peoples Bancorp
PEBO
$1.47B
$660K ﹤0.01%
22,826
+4,268
+23% +$126K
OII icon
2511
Oceaneering
OII
$4.77B
$659K ﹤0.01%
82,822
+1,520
+2% +$14.3K
DCPH
2512
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$658K ﹤0.01%
35,573
+227
+0.6% +$3.56K
ACVA icon
2513
ACV Auctions
ACVA
$1.3B
$657K ﹤0.01%
91,343
+26,184
+40% +$208K
MYOV
2514
DELISTED
Myovant Sciences Ltd.
MYOV
$657K ﹤0.01%
36,616
+7,709
+27% +$123K
MDGL icon
2515
Madrigal Pharmaceuticals
MDGL
$11.8B
$655K ﹤0.01%
10,068
+1,595
+19% +$111K
FLOT icon
2516
iShares Floating Rate Bond ETF
FLOT
$10.3B
$653K ﹤0.01%
12,992
-1,911
-13% -$96K
PENG
2517
Penguin Solutions Inc
PENG
$2.99B
$653K ﹤0.01%
41,192
+10,719
+35% +$195K
ACRS icon
2518
Aclaris Therapeutics
ACRS
$869M
$652K ﹤0.01%
41,392
+4,450
+12% +$70.1K
UMH
2519
UMH Properties
UMH
$1.36B
$651K ﹤0.01%
40,377
+3,097
+8% +$58.2K
MNTV
2520
DELISTED
Momentive Global Inc. Common Stock
MNTV
$650K ﹤0.01%
111,995
+1,414
+1% +$11K
ACRE
2521
Ares Commercial Real Estate
ACRE
$270M
$648K ﹤0.01%
62,019
+9,115
+17% +$118K
GBX icon
2522
The Greenbrier Companies
GBX
$1.46B
$648K ﹤0.01%
26,736
+2,293
+9% +$69.1K
UHT
2523
Universal Health Realty Income Trust
UHT
$594M
$647K ﹤0.01%
14,982
-339
-2% -$17.3K
CIB icon
2524
Grupo Cibest SA
CIB
$21.1B
$644K ﹤0.01%
26,416
-34,029
-56% -$982K
MATX icon
2525
Matsons
MATX
$6.18B
$644K ﹤0.01%
10,471
-16,857
-62% -$1.3M

Similar funds

Credit Suisse's Q3 2022 Portfolio in Review

As of Q3 2022, Credit Suisse held 4,574 positions worth $89.7B, down 6.6% from $96.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Credit Suisse's Q3 2022 filing shows 72 new, 2,420 increased, 1,279 reduced and 355 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 431,400 shares worth $43.3M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $205M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q3 2022 buy was iShares 0-3 Month Treasury Bond ETF: 431,400 shares worth $43.3M.
  • Credit Suisse added most to Apple in Q3 2022, an estimated $180M increase.
  • Credit Suisse's biggest Q3 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $205M.
  • Credit Suisse fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q3 2022, selling an estimated $40.9M.
  • Credit Suisse's ten largest holdings make up 19% of its $89.7B portfolio in Q3 2022.
  • Credit Suisse opened 72 new positions and closed 355 in Q3 2022.
  • Credit Suisse's portfolio value fell 6.6% quarter-over-quarter to $89.7B.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.